HSSB1 binds and protects p21 from ubiquitin-mediated degradation and positively correlates with p21 in human hepatocellular carcinomas

Oncogene

Volumn 30, Issue 19, 2011, Pages 2219-2229

  Xu, S ^a   Feng, Z ^a   Zhang, M ^a   Wu, Y ^a   Sang, Y ^a   Xu, H ^a   Lv, X ^a   Hu, K ^a   Cao, J ^a   Zhang, R ^a   Chen, L ^a   Liu, M ^a   Yun, J P ^a   Zeng, Y X ^a   Kang, T ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

cell cycle; hepatocellular carcinomas; hSSB1; p21; ubiquitin

Indexed keywords

P21 ACTIVATED KINASE; PROTEIN; PROTEIN HSSB1; UBIQUITIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CORRELATION ANALYSIS; DNA DAMAGE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION;

BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CELL DIVISION; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA-BINDING PROTEINS; G2 PHASE; GENE KNOCKDOWN TECHNIQUES; HUMANS; HYDROLYSIS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; PROTEIN BINDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, SMALL INTERFERING; UBIQUITIN;

EID: 79955861679     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.596     Document Type: Article

References (48)

1. Abbas T, Dutta A. (2009). p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer 9: 400-414.
2. Blagosklonny MV, Wu GS, Omura S, el-Deiry WS. (1996). Protea-some-dependent regulation of p21WAF1/CIP1 expression. Biochem Biophys Res Commun 227: 564-569.
3. Brustmann H. (2005). Immunohistochemical detection of human telomerase reverse transcriptase (hTERT) and c-kit in serous ovarian carcinoma: a clinicopathologic study. Gynecol Oncol 98: 396-402. (Pubitemid 41169150)
4. Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP et al. (1998). Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282: 1497-1501. (Pubitemid 28538613)
5. Chen MS, Ryan CE, Piwnica-Worms H. (2003). Chk1 kinase negatively regulates mitotic function of Cdc25A phosphatase through 14-3-3 binding. Mol Cell Biol 23: 7488-7497. (Pubitemid 37271450)
6. Child ES, Mann DJ. (2006). The intricacies of p21 phosphorylation: protein/protein interactions, subcellular localization and stability. Cell Cycle 5: 1313-1319. (Pubitemid 43894287)
7. Dotto GP. (2000). p21(WAF1/Cip1): more than a break to the cell cycle? Biochim Biophys Acta 1471: M43-M56.
8. Dulic V, Kaufmann WK, Wilson SJ, Tlsty TD, Lees E, Harper JW et al. (1994). p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 76: 1013-1023. (Pubitemid 24106382)
9. El-Deiry WS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J et al. (1994). WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 54: 1169-1174. (Pubitemid 24108052)
10. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM et al. (1993). WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825. (Pubitemid 23346378)
11. Ferguson AM, White LS, Donovan PJ, Piwnica-Worms H. (2005). Normal cell cycle and checkpoint responses in mice and cells lacking Cdc25B and Cdc25C protein phosphatases. Mol Cell Biol 25: 2853-2860. (Pubitemid 40381646)
12. Fukuchi K, Maruyama H, Takagi Y, Gomi K. (1999). Direct proteasome inhibition by clasto-lactacystin beta-lactone permits the detection of ubiquitinated p21(waf1) in ML-1 cells. Biochim Biophys Acta 1451: 206-210. (Pubitemid 29364260)
13. Gartel AL. (2006). Is p21 an oncogene? Mol Cancer Ther 5: 1385-1386. (Pubitemid 44070473)
14. Gartel AL, Tyner AL. (2002). The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol Cancer Ther 1: 639-649.
15. Huang J, Gong Z, Ghosal G, Chen J. (2009). SOSS complexes participate in the maintenance of genomic stability. Mol Cell 35: 384-393.
16. Inagaki Y, Yasui K, Endo M, Nakajima T, Zen K, Tsuji K et al. (2008). CREB3L4, INTS3, and SNAPAP are targets for the 1q21 amplicon frequently detected in hepatocellular carcinoma. Cancer Genet Cytogenet 180: 30-36. (Pubitemid 350192683)
17. Ivanovska I, Ball AS, Diaz RL, Magnus JF, Kibukawa M, Schelter JM et al. (2008). MicroRNAs in the miR-106b family regulate p21/ CDKN1A and promote cell cycle progression. Mol Cell Biol 28: 2167-2174. (Pubitemid 351429964)
18. Jascur T, Brickner H, Salles-Passador I, Barbier V, El Khissiin A, Smith B et al. (2005). Regulation of p21(WAF1/CIP1) stability by WISp39, a Hsp90 binding TPR protein. Mol Cell 17: 237-249. (Pubitemid 40138618)
19. Jin Y, Lee H, Zeng SX, Dai MS, Lu H. (2003). MDM2 promotes p21waf1/cip1 proteasomal turnover independently of ubiquity-lation. EMBO J 22: 6365-6377. (Pubitemid 37522593)
20. Kang T, Wei Y, Honaker Y, Yamaguchi H, Appella E, Hung MC et al. (2008). GSK-3 beta targets Cdc25A for ubiquitin-mediated proteolysis, and GSK-3 beta inactivation correlates with Cdc25A overproduction in human cancers. Cancer Cell 13: 36-47. (Pubitemid 350309739)
21. Kao JT, Chuah SK, Huang CC, Chen CL, Wang CC, Hung CH et al. (2007). P21/WAF1 is an independent survival prognostic factor for patients with hepatocellular carcinoma after resection. Liver Int 27: 772-781.
22. Lee S, Helfman DM. (2004). Cytoplasmic p21Cip1 is involved in Ras-induced inhibition of the ROCK/LIMK/cofilin pathway. J Biol Chem 279: 1885-1891. (Pubitemid 38084458)
23. Lee YH, Oh BK, Yoo JE, Yoon SM, Choi J, Kim KS et al. (2009). Chromosomal instability, telomere shortening, and inactivation of p21(WAF1/CIP1) in dysplastic nodules of hepatitis B virus-associated multistep hepatocarcinogenesis. Mod Pathol 22: 1121-1131.
24. Li R, Waga S, Hannon GJ, Beach D, Stillman B. (1994). Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair. Nature 371: 534-537. (Pubitemid 24306614)
25. Li XS, Rishi AK, Shao ZM, Dawson MI, Jong L, Shroot B et al. (1996). Posttranscriptional regulation of p21WAF1/CIP1 expression in human breast carcinoma cells. Cancer Res 56: 5055-5062. (Pubitemid 26374449)
26. Li Y, Bolderson E, Kumar R, Muniandy PA, Xue Y, Richard DJ et al. (2009). HSSB1 and hSSB2 form similar multiprotein complexes that participate in DNA damage response. J Biol Chem 284: 23525-23531.
27. Liu S, Bishop WR, Liu M. (2003). Differential effects of cell cycle regulatory protein p21(WAF1/Cip1) on apoptosis and sensitivity to cancer chemotherapy. Drug Resist Updat 6: 183-195. (Pubitemid 37129918)
28. Macleod KF, Sherry N, Hannon G, Beach D, Tokino T, Kinzler K et al. (1995). p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev 9: 935-944.
29. Maki CG, Howley PM. (1997). Ubiquitination of p53 and p21 is differentially affected by ionizing and UV radiation. Mol Cell Biol 17: 355-363. (Pubitemid 26425625)
30. Michieli P, Chedid M, Lin D, Pierce JH, Mercer WE, Givol D. (1994). Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res 54: 3391-3395. (Pubitemid 24225956)
31. Miyazaki M, Sakaguchi M, Akiyama I, Sakaguchi Y, Nagamori S, Huh NH. (2004). Involvement of interferon regulatory factor 1 and S100C/A11 in growth inhibition by transforming growth factor beta 1 in human hepatocellular carcinoma cells. Cancer Res 64: 4155-4161. (Pubitemid 38802418)
32. Moustakas A, Kardassis D. (1998). Regulation of the human p21/WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members. Proc Natl Acad Sci USA 95: 6733-6738. (Pubitemid 28278049)
33. O'Reilly MA. (2005). Redox activation of p21Cip1/WAF1/Sdi1: a multifunctional regulator of cell survival and death. Antioxid Redox Signal 7: 108-118. (Pubitemid 40187929)
34. Parker SB, Eichele G, Zhang P, Rawls A, Sands AT, Bradley A et al. (1995). p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells. Science 267: 1024-1027.
35. Qin LF, Ng IO, Fan ST, Ng M. (1998). p21/WAF1, p53 and PCNA expression and p53 mutation status in hepatocellular carcinoma. Int J Cancer 79: 424-428. (Pubitemid 28359743)
36. Richard DJ, Bolderson E, Cubeddu L, Wadsworth RI, Savage K, Sharma GG et al. (2008). Single-stranded DNA-binding protein hSSB1 is critical for genomic stability. Nature 453: 677-681. (Pubitemid 351769294)
37. Schoniger-Hekele M, Hanel S, Wrba F, Muller C. (2005). Hepato-cellular carcinoma-survival and clinical characteristics in relation to various histologic molecular markers in Western patients. Liver Int 25: 62-69. (Pubitemid 40298246)
38. Sheikh MS, Li XS, Chen JC, Shao ZM, Ordonez JV, Fontana JA. (1994). Mechanisms of regulation of WAF1/Cip1 gene expression in human breast carcinoma: role of p53-dependent and independent signal transduction pathways. Oncogene 9: 3407-3415. (Pubitemid 24359376)
39. Sherr CJ, Roberts JM. (1999). CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13: 1501-1512. (Pubitemid 29297917)
40. Shiohara M, Akashi M, Gombart AF, Yang R, Koeffler HP. (1996). Tumor necrosis factor alpha: posttranscriptional stabilization of WAF1 mRNA in p53-deficient human leukemic cells. J Cell Physiol 166: 568-576. (Pubitemid 26095483)
41. Shiraki K, Wagayama H. (2006). Cytoplasmic p21(WAF1/CIP1) expression in human hepatocellular carcinomas. Liver Int 26: 1018-1019. (Pubitemid 44323422)
42. Skaar JR, Richard DJ, Saraf A, Toschi A, Bolderson E, Florens L et al. (2009). INTS3 controls the hSSB1-mediated DNA damage response. J Cell Biol 187: 25-32.
43. Tanaka H, Yamashita T, Asada M, Mizutani S, Yoshikawa H, Tohyama M. (2002). Cytoplasmic p21(Cip1/WAF1) regulates neurite remodeling by inhibiting Rho-kinase activity. J Cell Biol 158: 321-329.
44. Touitou R, Richardson J, Bose S, Nakanishi M, Rivett J, Allday MJ. (2001). A degradation signal located in the C-terminus of p21WAF1/CIP1 is a binding site for the C8 alpha-subunit of the 20S proteasome. EMBO J 20: 2367-2375. (Pubitemid 32452854)
45. Xiao J, Zhang Z, Chen GG, Zhang M, Ding Y, Fu J et al. (2009). Nucleophosmin/B23 interacts with p21WAF1/CIP1 and contributes to its stability. Cell Cycle 8: 889-895.
46. Xu SB, Liu XH, Li BH, Zhang Y, Yuan J, Yuan Q et al. (2009). DNA methylation regulates constitutive expression of Stat6 regulatory genes SOCS-1 and SHP-1 in colon cancer cells. J Cancer Res Clin Oncol 135: 1791-1798.
47. Zhang F, Wu J, Yu X. (2009). Integrator3, a partner of single-stranded DNA-binding protein 1, participates in the DNA damage response. J Biol Chem 284: 30408-30415.
48. Zhou BP, Liao Y, Xia W, Spohn B, Lee MH, Hung MC. (2001). Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phos-phorylation in HER-2/neu-overexpressing cells. Nat Cell Biol 3: 245-252. (Pubitemid 32201319)